norfluoxetine has been researched along with Emesis in 1 studies
norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study investigated potential modifications to the pharmacokinetic profile of milnacipran at steady-state when it is substituted for fluoxetine without any washout period." | 2.72 | Lack of pharmacokinetic interaction when switching from fluoxetine to milnacipran. ( Chassard, D; Hermann, P; Puozzo, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Puozzo, C | 1 |
| Hermann, P | 1 |
| Chassard, D | 1 |
1 trial available for norfluoxetine and Emesis
| Article | Year |
|---|---|
Lack of pharmacokinetic interaction when switching from fluoxetine to milnacipran.
Topics: Adult; Area Under Curve; Cyclopropanes; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Drug | 2006 |